Show cover of CEimpact Podcast

CEimpact Podcast

The CEimpact Podcast features three shows; GameChangers, Precept2Practice, and LevelUp. The GameChangers podcast, hosted by Geoff Wall, features the latest game changing  pharmacotherapy advances impacting patient care. New episodes arrive every Monday, and users can earn CPE + CME from each episode. The Precept2Practice podcast, hosted by Kathy Scott, features information and resources you can use to precept students and residents. New episodes arrive on the third Wednesday of every month. The LevelUp podcast, hosted by Ashlee Klevens Hayes, features conversations surrounding the best practices and products for pharmacy practices and business. New episodes with new guests arrive every Wednesday. To support our shows, give us a follow and check back each week for our latest episodes. 

Tracks

A New Fungus Among Us
Several outbreaks of a relatively new, resistant fungal infection - candida auris - have been reported in the Pacific Northwest. It is highly contagious and its mortality has approached 60%. Listen in as we discuss what to watch for and how to prepare if this reaches your geography.THE GAMECHANGER: Candida auris is resistant to most antifungals, has high plasticity, and its mortality approaches 60%.Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceCristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, Boni S, Pontali E. An Overview on Candida auris in Healthcare Settings. J Fungi (Basel). 2023 Sep 8;9(9):913. doi: 10.3390/jof9090913. PMID: 37755021; PMCID: PMC10532978. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss characteristics of C. auris infections that make it difficult to avoid outbreaks 2. Describe issues surrounding treatment of serious infections with C. auris 0.05 CEU/0.5 HrUAN: 0107-0000-24-058-H01-PInitial release date: 2/26/2024Expiration date: 2/26/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
24:17 2/26/24
Creative Ways to Engage Your Students and Residents
Do you feel like it is getting more difficult to engage your students or residents on your rotation and keep them engaged? Or maybe you personally feel a little bored with the same old activities and strategies. In this episode, preceptors Beth Cady and Carrie Vogler of Southern Illinois University Edwardsville on some creative strategies they use to engage their learners. Kathy Schott, PhDVice President, Education & OperationsCEimpactKate Newman, PharmDDirector of Experiential EducationSouthern Illinois University EdwardsvilleElizabeth Cady, PharmDClinical Associate ProfessorSouthern Illinois University EdwardsvilleCarrie VoglerClinical ProfessorSouthern Illinois University EdwardsvilleGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss barriers to effectively engaging students and residents in their experiential learning 2. Identify creative strategies for engaging students and residents to optimize their learning0.075 CEU/0.75 HrUAN: 0107-0000-24-059-H99-P Initial release date: 2/21/2024Expiration date: 2/21/2027Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.ChatGPT 3.5 (https://chat.openai.com) was utilized in the planning of this Precept2Podcast episode.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram
37:35 2/21/24
Is Measles Back?
With pockets of measles outbreaks throughout the country, we discuss the reasons and strategize ways pharmacy can impact vaccination rates in their communities.  The GameChangerMeasles was essentially eliminated from the US in 2000. Now, we are seeing a resurgence of outbreaks that have prompted the CDC to issue warnings and reminders of the importance of proper vaccination.  Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthElizabeth Skoy, PharmDProfessorNorth Dakota State UniversityLacy Epperson, PharmD Clinical Pharmacist Mitchell’s Drug Store Referencehttps://www.usatoday.com/story/news/health/2024/01/26/cdc-issues-alert-measles-global/72365871007/ Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the CDC warning about the increased incidence of measles 2. Discuss ways pharmacy can have an impact on increasing vaccination rates and decreasing measles outbreaks 0.05 CEU/0.5 HrUAN: 0107-0000-24-057-H01-P Initial release date: 2/19/2024Expiration date: 2/19/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
28:17 2/19/24
Cold Injuries and Frostbite
With record-cold temperatures in much of the United States this winter, a high number of cold injuries have been reported. This podcast discusses prevention and treatment for hypothermia and frostbite. Brrrrr! The GameChangers: Frostbite prevention using layers and heating measuresHypothermia treatment using external and internal heating Frostbite treatment with anticoagulants HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health Referencehttps://www-nejm-org./doi/10.1056/NEJMra1800868?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Differentiate between types of hypothermia2. Discuss treatments for frostbite0.05 CEU/0.5 HrUAN: 0107-0000-24-051-H01-P Initial release date: 2/12/2024Expiration date: 2/12/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
29:07 2/12/24
2024 Diabetes Standards
The American Diabetes Association has released the 2024 Standards of Care for people with Type 1 and Type 2 Diabetes. Join us as we talk with one of our favorite diabetes experts, Dr. Sue Cornell, about the major shifts in diabetes care that are omnipresent in this year's guideline updates.  The GameChangerDiabetes treatment is shifting to prevention and delay. After a long period of time without many advances, we are now on the brink of changing the game in diabetes care and prevention with new drugs and technologies.  HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthSusan Cornell, PharmD, CDCES, FAPhA, FADCESDiabetes Care & Education SpecialistMidwestern University College of Pharmacy  Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss highlights of the 2024 American Diabetes Association Standards of Care Update 2. Describe the landscape of diabetes care as it shifts to prevention and delay0.05 CEU/0.5 HrUAN: 0107-0000-24-050-H01-PInitial release date: 2/5/2024Expiration date: 2/5/2025Additional CPE details can be found here.Join us Tuesday, February 13th from 7-9pm for our next live course:From A1C to Z: A Sweet Update on Diabetes GuidelinesThis course will review the latest revisions to the American Diabetes Association (ADA) Standards of Care specifically highlighting the rising rates of obesity-related to diabetes, a pressing health concern affecting millions worldwide and often referred to as "diabesity". Learners will gain insights into nuances related to medication management and therapeutic decision-making for patients with diabetes. Content will provide guidance for reviewing and crafting patient-centered treatment strategies that holistically address glucose management while fostering improvements in cardio-metabolic, kidney, liver, and cognitive health for individuals grappling with diabetes and related comorbidities. Follow CEimpact on Social Media:LinkedInInstagram
34:10 2/5/24
Once Weekly Basal Insulin
Insulin icodec is the first class of long-acting insulin to be administered only once a week. Join host, Jen Moulton, as she discusses the safety and efficacy of insulin icodec with guest, Geoff Wall.The GameChangerInsulin icodec is the first of the ultra long-acting insulins with once weekly dosing. Multiple clinical studies have suggested these pharmacokinetics work. A new meta-analysis suggests that insulin icodec is more effective than other basal insulins and at least as safe concerning hypoglycemia.Jen Moulton, RPhPresident + FounderCEimpactGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceWang P, Zhang Y, Xu W, et al. Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Diabetol Metab Syndr. 2024 Jan 3;16(1):3. doi: 10.1186/s13098-023-01240-5. PMID: 38172995; PMCID: PMC10763463.https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-023-01240-5#Sec19 Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the chemical and structural changes that make icodec different from other basal insulins 2. Discuss the results of the meta-analysis about insulin icodec0.05 CEU/0.5 HrUAN: 0107-0000-24-043-H01-PInitial release date: 1/29/2024Expiration date: 1/29/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
30:15 1/29/24
Updated Alcohol Abuse Guidelines
Alcohol Use Disorder (AUD) and cirrhosis are common medical conditions with significant morbidity and mortality. Join host, Geoff Wall, as he evaluates the new  American College of Gastroenterology guidelines.  The GameChangerThe MELD score is now preferred over the Madrey score for assessing mortality. Baclofen is the primary treatment for reducing consumption and craving in alcohol use disorder. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceJophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, Shah VH. ACG Clinical Guideline: Alcohol-Associated Liver Disease. Am J Gastroenterol. 2024 Jan 1;119(1):30-54. doi: 10.14309/ajg.0000000000002572. Epub 2023 Sep 1. PMID: 38174913.https://journals.lww.com/ajg/fulltext/2024/01000/acg_clinical_guideline__alcohol_associated_liver.13.aspx?context=featuredarticles&collectionid=5 Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the initial treatment of a patient admitted with acute alcoholic hepatitis2. Describe a pharmacotherapeutic plan for adjunctive treatment of alcohol use disorder0.05 CEU/0.5 HrUAN: 0107-0000-24-042-H01-P Initial release date: 1/22/2024Expiration date: 1/22/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
32:16 1/22/24
(Re)Teaching Professional Communication
Communication is ‘an essential duty’ of a pharmacist and the cornerstone of quality patient care. And yet, it continues to be one of the most common frustrations reported by preceptors when working with students and residents. Many factors may be at play, including a pandemic, as well as a digital society where so much communication happens in quick, abbreviated bytes.On this episode, guest Christine Klein reminds us of the many facets of communication, the complex range of reasons some students and residents may struggle, and how we as mentors and teachers can support their development in this area effectively.HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestDr. Christine Klein, PharmDVice-Chair for Experiential EducationClinical Associate ProfessorMercer University College of PharmacyGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss the importance of strong communication skills for students and residents 2. Describe the preceptor's role in fostering professional communication 0.05 CEU/0.5 HrUAN: 0107-0000-24-041-H99-P Initial release date: 1/17/2024Expiration date: 1/17/2025Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram
32:34 1/17/24
Thiazide Diuretics and Hyponatremia
Hyponatremia is a side effect of most diuretics but the incidence from thiazides is unknown. Join host, Geoff Wall, as he evaluates a new study from Denmark evaluating hyponatremia and thiazides. The GameChangerThiazide diuretics are considered first-line therapy but electrolyte side effects are underevaluated. A new study suggests hyponatremia is significantly more common than previously reported, especially in the elderly. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceAndersson NW, Wohlfahrt J, Feenstra B, et al. Cumulative Incidence of Thiazide-Induced Hyponatremia: A Population-Based Cohort Study. Ann Intern Med. 2023 Dec 19. doi: 10.7326/M23-1989. Epub ahead of print. PMID: 38109740.https://www.acpjournals.org/doi/abs/10.7326/M23-1989?journalCode=aim Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of thiazides in hypertension and their adverse effects 2. Assess the strengths and weaknesses of the Andersson et al study0.05 CEU/0.5 HrUAN: 0107-0000-24-032-H01-PInitial release date: 1/15/2024Expiration date: 1/15/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
29:50 1/15/24
Sickle Cell's Cure: CRISPR
Sickle cell disease (SCD) is a devastating medical condition causing pain, fatigue, and early mortality. Join host, Geoff Wall, as he evaluates a new gene therapy via CRISPR that may cure SCD. The GameChangerCRISPR is a new method to develop targeted gene editing treatments. Lovo-cel is the first FDA-approved therapy and may treat sickle cell disease (SCD) - for only $2 million. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceFDA Approval. https://www.fda.gov/vaccines-blood-biologics/lyfgenia. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss what CRISPR is and how it can be used to treat diseases 2. Describe the use of lovotibeglogene autotemcel (lovo-cel) for sickle cell disease and its safety and efficacy data 0.05 CEU/0.5 HrUAN: 0107-0000-24-031-H01-PInitial release date: 1/8/2024Expiration date: 1/8/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
27:14 1/8/24
Atrial Fibrillation Guideline Update: Part II
Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, with guest Matt Boyd, as they evaluate the pharmacotherapy changes in the new guidelines in this two-part episode.The GameChangerRate and rhythm control medications largely have the same clinical outcomes. Patients with heart failure with reduced ejection fraction should try rhythm control first. Monitoring is key for atrial fibrillation pharmacotherapy. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthGuest Mathew Boyd, PharmD Clinical PharmacistUnity PointReferenceJoglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)06465-3. doi: 10.1016/j.jacc.2023.08.017. Epub ahead of print. PMID: 38043043.https://www.jacc.org/doi/10.1016/j.jacc.2023.08.017Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss rate versus rhythm control in patients with atrial fibrillation 2. Develop a monitoring plan and selection of medications in rhythm control0.05 CEU/0.5 HrUAN: 0107-0000-24-030-H01-PInitial release date: 1/5/2024Expiration date: 1/5/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
37:23 1/1/24
Atrial Fibrillation Guideline Update: Part I
Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, as he evaluates the first half of the guidelines in this two-part episode.The GameChangerDifferent stratifying types of atrial fibrillation no longer exist. Additionally, left atrial occlusive devices are now recommended as first-line therapy for the prevention of stroke, though anticoagulants are the treatment of choice. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceJoglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)06465-3. doi: 10.1016/j.jacc.2023.08.017. Epub ahead of print. PMID: 38043043.https://www.jacc.org/doi/10.1016/j.jacc.2023.08.017 Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe new definitions of atrial fibrillation and risk factors for stroke 2. Discuss mechanical prevention of stroke in high risk patients 0.05 CEU/0.5 HrUAN: 0107-0000-23-401-H01-PInitial release date: 12/25/2023Expiration date: 12/25/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
30:34 12/28/23
Artificial Intelligence: What Does it Mean for Clinical Teaching?
Utter the words "Artificial Intelligence" to other preceptors and pharmacy faculty, and you might get a reaction that ranges anywhere from fear and anxiety to excitement. In this insightful discussion, we explore the fundamental question of what AI is and its diverse application in shaping the landscape of pharmacy education. Guest Tim Aungst delves into the challenges surrounding student and resident access to AI tools, shedding light on the challenges and opportunities that access brings.  HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestTimothy Dy Aungst, PharmD, RPhAssociate Professor of Pharmacy PracticeMassachusetts College of Pharmacy and Health SciencesGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. List a primary advantage of using artificial intelligence (AI)2. Discuss ways in which access to AI should inform teaching strategies.0.05 CEU/0.5 HrUAN: 0107-0000-23-402-H99-PInitial release date: 12/20/2023Expiration date: 12/20/2024Additional CPE details can be found here.Dr. Schott has no relevant financial relationships with ineligible companies to disclose.Dr. Aungst reports he is a consultant for Otsuka and an advisor for Digital Therapeutics Alliance. All relevant financial relationships have been mitigated. This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram
40:45 12/20/23
Revolutionizing Healthcare with Pharmacogenomic Testing
Join Ashlee as she talks with Ina, the Director of Clinical Operations at RxGenomix, about the fascinating world of pharmacogenomics. Throughout this episode, Ashlee and Ina get into the nitty-gritty of pharmacogenomic testing - a game-changer in ensuring the right medication is administered to the right patient at the right time and dose. Listen to this episode to equip yourself with the knowledge to grasp the potential and significance of pharmacogenomics in patient care. Whether a healthcare professional or simply curious, it's time to step into the future of personalized medicine.In this episode, the two discuss:- Pharmacogenomics & their implications - The role genetics play in influencing medication responses- Integrating pharmacogenomics into routine patient care- The future of pharmacogenomicsDr. Ina Liko received her Doctor of Pharmacy degree at the University of Illinois at Chicago where she was initially exposed to pharmacogenomics. She then completed a clinical residency program at Monroe Clinic where her research project was focused on the implementation of pharmacogenomics. After this initial exposure to the clinical application of pharmacogenomics, she gained experience in implementing it in a larger scale by completing a fellowship in the Clinical Implementation of Pharmacogenomics at the University of Colorado where she was exposed to a systematic approach of implementing pharmacogenomics in various therapeutic classes. Dr. Liko now serves as the Director of Clinical Pharmacogenomics Operations at RxGenomix where she works collaboratively in a multidisciplinary team leading the clinical operations. To learn more about CEimpact's By Design memberships, click here. To learn more about the CEimpact Advanced PGx training, click hereFollow CEimpact on Social Media:LinkedInInstagram
24:01 12/20/23
The Frequent Use of Digoxin
One of the oldest medications in our pharmacopeia is digoxin. It may be used for atrial fibrillation and heart failure, although not as a first-line agent. Despite this, digoxin use is on the rise. Join host, Geoff Wall, as he evaluates why more prescribers are using digoxin.The GameChangerNo new randomized controlled trials have been published to justify the increased use of digoxin. However, when used, providers should routinely monitor digoxin levels.  HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceGazzaniga G, Menichelli D, Scaglione F, et al. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses. Eur J Clin Pharmacol. 2023 Apr;79(4):473-483. doi: 10.1007/s00228-023-03470-y. Epub 2023 Mar 6. PMID: 36872367; PMCID: PMC10039090.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039090/ Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Apply information on the potential uses and harms of digoxin 2. Apply a strategy for monitoring digoxin in heart failure patients 0.05 CEU/0.5 HrUAN: 0107-0000-23-400-H01-PInitial release date: 12/18/2023Expiration date: 12/18/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
25:24 12/18/23
Jen's Top 5 Takeaways of 2023
Join Ashlee as she talks with Jen Moulton, the president of CEimpact, about her top five takeaways from a transformative year in pharmacy education and patient care.  Listen to this episode to reflect on, learn, and apply the biggest lessons 2023 taught us, from the every-day practices that define us to the big picture within pharmacy education that leads us.  In this episode, the two discuss:- The power of focus, prioritization, and efficient processes within CEimpact.- Technology's ever-growing influence on pharmacy education.- How building connections with clients, team members, and customers can prevent burnout and foster positivity.- CEimpact's efforts to address pharmacy burnout. To learn more about CEimpact's By Design memberships, click here. Follow CEimpact on Social Media:LinkedInInstagram
21:11 12/13/23
Association between Immunization Status and Alzheimer's Disease
Alzheimer's Disease is a progressive terminal disease. Many treatments are focused on lifestyle modification to delay diagnosis and onset. Join host, Geoff Wall, with guest Jake Galdo, as they look at a new study evaluating the association between vaccines and the development of Alzheimer's Disease.  The GameChangerPostviral inflammation may play a role in the development of Alzheimer's Disease. A recent claims-based study found an association between immunization status and the development of Alzheimer's Disease.  HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCourse Content and Developer, CEimpactManaging Network Facilitator, CPESN Health EquityCEO, Seguridad ReferenceHarris K, Ling Y, Bukhbinder AS, et al. The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching. J Alzheimers Dis. 2023;95(2):703-718. doi: 10.3233/JAD-221231. PMID: 37574727; PMCID: PMC10578243. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the potential mechanisms of inflammation and viral infections with the development of Alzheimer's Disease.2. Describe the study discussed and its application in guiding patients to receive vaccines.0.05 CEU/0.5 HrUAN: 0107-0000-23-367-H01-PInitial release date: 12/11/2023Expiration date: 12/11/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
31:53 12/11/23
Pancreatic Enzymes for Exocrine Dysfunction
Exocrine enzyme dysfunction is far more common than many primary care practitioners realize. Using pancreatic enzymes can help with symptoms and vitamin absorption. Join host, Geoff Wall, as he reviews new guidelines on the appropriate use of pancreatic enzymes. The GameChangerChronic pancreatitis is the most common cause of exocrine dysfunction in adults. All pancreatic enzymes are equally effective; however, the use of pancreatic enzymes to treat chronic pain is controversial. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceWhitcomb DC, Buchner AM, Forsmark CE. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. Gastroenterology. 2023 Nov;165(5):1292-1301. doi: 10.1053/j.gastro.2023.07.007. Epub 2023 Sep 20. PMID: 37737818.https://www.gastrojournal.org/article/S0016-5085(23)04780-7/fulltext Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss common symptoms and diagnoses associated with exocrine dysfunction. 2. Describe challenges associated with the use of pancreatic enzymes.0.05 CEU/0.5 HrUAN: 0107-0000-23-366-H01-PInitial release date: 12/4/2023Expiration date: 12/4/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
31:07 12/4/23
What's Your Plan? Rethinking Professional Development for Preceptors
The world of healthcare is changing and so are our students and residents. If you are in a precepting role, you are experiencing some challenges in navigating these new waters.In this episode, Logan Murry, CPD champion, makes professional development practical, effective, and intentional. Listen in to learn how taking time to practice intentional CPD can make you a more effective, and more fulfilled preceptor.HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestLogan T. Murry, PharmD, PhDAssistant Director of the Continuing Pharmacy Education Accreditation ProgramAccreditation Council for Pharmacy Education (ACPE)Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. Describe the Continuing Professional Development (CPD) cycle and its key components. 2. Articulate the value of practicing intentional CPD as a preceptor.0.05 CEU/0.5 HrUAN: 0107-0000-23-390-H99-P  Initial release date: 11/29/2023Expiration date: 11/29/2024Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram
26:41 11/29/23
Fezolinetant for Vasomotor Symptoms in Menopause
Menopausal vasomotor symptoms occur in about 80% of women and have a significant impact on quality of life. Hormone replacement therapy works well; however, it is often underused. Join host, Geoff Wall, as he evaluates Fezolinetant, a new medication to treat 'hot flashes.' The GameChangerHRT is vastly underused in menopausal women. Gabapentin and SNRIs may help with some vasomotor symptoms. Fezolinetant is effective for hot flashes and seems to be well tolerated. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceLederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023 Apr 1;401(10382):1091-1102. doi: 10.1016/S0140-6736(23)00085-5. Epub 2023 Mar 13. PMID: 36924778.https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00085-5/fulltext Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the pros and cons of hormone replacement therapy in women with vasomotor symptoms.2. Discuss the role of fezolinetant for treatment of vasomotor symptoms.  0.05 CEU/0.5 HrUAN: 0107-0000-23-365-H01-PInitial release date: 11/27/2023Expiration date: 11/27/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
29:10 11/27/23
Convalescent Plasma in COVID
Respiratory failure from COVID-19 should be treated as soon as possible. Join host, Geoff Wall, as he evaluates the the role of convalescent plasma in treating patients with COVID-19 and on mechanical ventilation.  The GameChangerCOVID-19 is still a significant concern acutely and for long-term complications. Convalescent plasma may benefit severely ill COVID-19 patients on mechanical ventilation and with acute respiratory distress syndrome (ARDS). HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceMisset B, Piagnerelli M, Hoste E, Dardenne N, Grimaldi D, Michaux I, De Waele E, Dumoulin A, Jorens PG, van der Hauwaert E, Vallot F, Lamote S, Swinnen W, De Schryver N, Fraipont V, de Mey N, Dauby N, Layios N, Mesland JB, Meyfroidt G, Moutschen M, Compernolle V, Gothot A, Desmecht D, Taveira da Silva Pereira MI, Garigliany M, Najdovski T, Bertrand A, Donneau AF, Laterre PF. Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients. N Engl J Med. 2023 Oct 26;389(17):1590-1600. doi: 10.1056/NEJMoa2209502. Epub 2023 Oct 25. PMID: 37889107.https://www.nejm.org/doi/full/10.1056/NEJMoa2209502?query=featured_home Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the latest NIH treatment guidelines for COVID-19 patients who are hospitalized2. Describe the use of convalescent plasma in the context of a COVID-19 treatment algorithm0.05 CEU/0.5 HrUAN: 0107-0000-23-354-H01-P Initial release date: 11/20/2023Expiration date: 11/20/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
23:23 11/20/23
Pharmacy Fast Facts: Drug Information vs. RX Continuing Education
Join Ashlee as she talks with Derek Borkowski, CEO and founder of Pyrls about the journey that led to the creation of Pyrls. Alongside this, Derek discusses Pyrls' partnership with CEimpact and the future of Pyrls  as a company.Pyrls is an online drug information provider that focuses on design and simplicity in their delivery of that information. Through an deeper dive into Pyrls, this episode offers up an exclusive behind-the-scenes glimpse into the future of digital health and the role of technology in the medical field.  In this episode, the two discuss:- The creation of Pyrls - Pyrls' impact on the healthcare world- Pyrls' partnership with CEimpact- The future of Pyrls To learn more about CEimpact's By Design memberships, click here. Follow CEimpact on Social Media:LinkedInInstagram
25:21 11/15/23
The ACORN Study: Nephrotoxoicity in Antibiotics
Piperacillin/tazobactam and vancomycin have been reported in numerous clinical trials to be associated with acute kidney injury. Comparatively, cefepime with vancomycin may increase neurotoxic effects. Join host, Geoff Wall, as he evaluates a new randomized controlled trial evaluating the safety of these medications. The GameChangerVancomycin, even at appropriate doses, can cause nephrotoxicity. Piperacillin/tazobactam does not seem to increase the risk of adverse kidney outcomes. However, cefepime is associated with an increased risk of neurologic toxicity. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceTong SYC, Venkatesh B, McCreary EK. Acute Kidney Injury With Empirical Antibiotics for Sepsis. JAMA. 2023;330(16):1531–1533. doi:10.1001/jama.2023.18591https://jamanetwork.com/journals/jama/fullarticle/2810593 Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the risk of nephrotoxicity with piperacillin/tazobactam2. Discuss the factors that exacerbate neurologic adverse effects with cefepime0.05 CEU/0.5 HrUAN: 0107-0000-23-353-H01-P Initial release date: 11/13/2023Expiration date: 11/13/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
30:22 11/13/23
HIV Prevention and the Role of Pharmacists
Join Ashlee as she talks with Bernadette Jakeman, an ID-HIV specialized prescribing pharmacist and associate professor at the University of New Mexico College of Pharmacy. Her expertise lies in infectious diseases and HIV, a field that she's deeply passionate about and has dedicated her career to.Listen in as she takes us on a fascinating journey, recounting her unique trajectory in the field of pharmacy, her experiences with an HIV specialist in an outpatient setting, and the incredibly impactful work she is currently doing within the HIV community.In this episode, the two discuss: - Bernadette's unique pharmacy career path- Bernadette's work within the HIV community - How pharmacists play a role in HIV prevention- The updated Pre-Exposure Prophylaxis guidelines For those keen on learning more or who work in the field, Bernadette has prepared an insightful course titled "Preparing for Tomorrow: A Pharmacist Guide to HIV Prevention". So, gear up to learn, engage, and feel empowered to discuss PrEP with patients and advocate for those who need it.To learn more about CEimpact's By Design memberships and to gain access to Bernadette's course, click here.Follow CEimpact on Social Media:LinkedInInstagram
15:28 11/8/23
Sarilumab and Polymyalgia Rheumatica
Polymyalgia rheumatica is a common rheumatic disorder. Steroids are the mainstay of therapy despite significant adverse reactions. Join host, Geoff Wall, as he evaluates a new treatment for PMR.The GameChangerSarilumab is now FDA-approved for relapsing polymyalgia rheumatica. Sarilumab can be an alternative to long-term steroid therapy or methotrexate. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceSpiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. PMID: 37792612.https://www.nejm.org/doi/full/10.1056/NEJMoa2303452 Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the diagnosis and treatment of polymyalgia rheumatica 2. Assess the SAPHYR study and the role of sarilumab for treatment of polymyalgia rheumatica 0.05 CEU/0.5 HrUAN: 0107-0000-23-352-H01-P Initial release date: 11/6/2023Expiration date: 11/6/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
26:10 11/6/23
Financial Wellness for Pharmacists
Join Ashlee and Tim Ulbrich, pharmacist and founder of Your Financial Pharmacist, in this week's Level Up episode as they discuss Tim's career, advice, and resources that pharmacists can use in the journey toward attaining financial wellness. Tim Ulbrich, pharmacist & CEO of Your Financial Pharmacist, set out to help pharmacists solve this issue by helping them develop financial planning and organization skillsIn this episode, the two discuss:- How Tim's blog developed into the Your Financial Pharmacist company- Tim's best tips for pharmacists hoping to work towards financial wellness - The upcoming CEimpact By Design course 'Dollars and Sense: Guidance for Building a Strong Financial Foundation', a course that Tim helped create. To learn more about CEimpact's By Design memberships and to gain access to Tim's course, click here.To get in touch with Your Financial Pharmacist, click here. Follow CEimpact on Social Media:LinkedInInstagram
21:50 11/1/23
Is Enteric Aspirin Worth It?
There are numerous formulations of aspirin available over-the-counter often advertised to decrease gastric issues. Join host, Geoff Wall, as he evaluates a new study to see if enteric aspirin is worth the extra money and effort. The GameChangerBuffered and coated aspirin are purported to cause fewer gastric adverse events. However, no efficacy or safety differences exist in the various formulations of aspirin. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceSleem A, Effron MB, Stebbins A, et al. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. Published online October 04, 2023. doi:10.1001/jamacardio.2023.3364https://jamanetwork.com/journals/jamacardiology/fullarticle/2809795?resultClick=1 Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the history of various formulations of aspirin on the US market 2. Discuss the results and limitations of the ADAPTABLE study 0.05 CEU/0.5 HrUAN: 0107-0000-23-331-H01-PInitial release date: 10/30/2023Expiration date: 10/30/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
23:53 10/30/23
Pharmacy Technician by Choice
Ever imagine what it's like to evolve from a retail pharmacy worker to a celebrated pharmacy technician trainer? Join Ashlee as she talks with Nicole Foster, the manager of pharmacy technician and client education at CEimpact about her inspiring journey. During this episode, the two discuss- Nicole's career and mentors - The essential shift in the perceptions surrounding pharmacy technicians- Nicole's predictions about the future of pharmacy techniciansTo learn more about our Pharmacist by Design membership, click here. Follow CEimpact on Social Media:LinkedInInstagram
27:43 10/25/23
Hypertensive Urgency
Hypertensive urgency - asymptomatic patients with elevated blood pressure - is frequently treated in the hospital and outpatient setting. Join host, Geoff Wall, as he critically examines the evidence to assess risk over benefit. The GameChangerTreatment of asymptomatic hypertension has not been shown to improve clinical outcomes. Recent data highlights the risk with increased mortality through aggressive management. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceAnderson TS, Herzig SJ, Jing B, et al. Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults. JAMA Intern Med. 2023;183(7):715–723. doi:10.1001/jamainternmed.2023.1667https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2805021 Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the difference between hypertensive urgency and emergency2. Discuss recent data about the possible harms of treating asymptomatic hypertension in the hospital setting0.05 CEU/0.5 HrUAN: 0107-0000-23-330-H01-PInitial release date: 10/23/2023Expiration date: 10/23/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
28:33 10/23/23
Club "J" - Making Journal Clubs Fun and Effective
Think journal clubs are a heavy lift? That they can't be done in a small pharmacy environment? Worried that you don't have enough statistical savvy? Listen to this episode and you'll discover how journal clubs can be incorporated into just about any setting with some simple strategies. The value they bring is immense - NAPLEX preparation for graduating students, expanded clinical knowledge for the learner and staff, the development of confidence and communication skills in your students and residents, and much more.In this episode, I talked with Dr. Valerie Coppenrath, a drug information guru and preceptor for both residents and students. She shares some background on the concept, and also provides us with some practical strategies for taking a more intentional approach to supporting our students and residents in their own professional identity journey. And who knows, maybe we’ll learn a little about ourselves along the way as well. Kathy Schott, PhDVice President, Education & OperationsCEimpactValerie Coppenrath, PharmDAssociate Professor of Pharmacy PracticeMassachusetts College of Pharmacy and Health SciencesGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE InformationLearning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss the advantages and challenges with conducting a journal club in a range of pharmacy settings. 2. List strategies for effective journal club selection.3. Describe strategies for overcoming barriers associated with setting up a successful journal club. 0.05 CEU/0.5 HrUAN: 0107-0000-23-342-H99-PInitial release date: 10/18/2023Expiration date: 10/18/2026Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Want more information on this and related topics?Mastering Journal Club Facilitation: A Toolkit for Engaging LearnersThis comprehensive collection of resources, tools, and best practice tips has been designed to help you facilitate an organized, effective, and engaging journal club experience, regardless of where you practice.Journal Club Toolkit for LearnersA companion to the toolkit for preceptors, this robust resource provides residents and students with checklists, templates, guidance on journal selection, and much more.Biostatistics RefresherThis course provides a crash course review in statistics to help you evaluate the literature and communicate its implications to providers and patients.As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask your experiential program director if you are a member so that you can access it all for free AND get CE credit!Follow CEimpact on Social Media:LinkedInInstagram
33:33 10/18/23